Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice

Area of Science:

• Virology
• Vaccinology
• Nanotechnology

Background:

• Rotaviruses are a leading cause of severe diarrhea in children globally, resulting in significant mortality and economic burden.
• Current rotavirus vaccines, despite their implementation, do not fully prevent disease, necessitating the development of new, highly effective prevention strategies.

Purpose of the Study:

• To evaluate the efficacy of a novel S-VP8* nanoparticle vaccine candidate against rotavirus infection in a mouse model.
• To assess the protective immune response generated by the S-VP8* vaccine against homologous rotavirus challenge.

Main Methods:

• Construction of S-VP8* nanoparticles displaying murine rotavirus (EDIM strain) VP8* antigens (S-mVP8*).
• Immunization of mice with the S-mVP8* vaccine.
• Challenge of immunized mice with the homologous murine EDIM rotavirus and assessment of virus shedding.

Main Results:

• Immunization with S-mVP8* induced high titers of anti-EDIM VP8* IgG antibodies.
• The S-mVP8* nanoparticle vaccine demonstrated high efficacy (97%) in protecting mice against rotavirus challenge, measured by reduced virus shedding.

Conclusions:

• The polyvalent S-VP8* nanoparticle vaccine is a promising candidate for rotavirus prevention.
• Further development of this nanoparticle-based vaccine strategy is warranted based on its high efficacy in a preclinical challenge model.